Equities research analysts at StockNews.com initiated coverage on shares of NeuroMetrix (NASDAQ:NURO – Get Free Report) in a research note issued to investors on Thursday. The firm set a “sell” rating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback